Coegin Pharma
4,5
SEK
+8,96 %
Mindre end 1K følgere
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+8,96%
+0,9%
+16,88%
+18,73%
-15,09%
+47,54%
-83,84%
+311,05%
-85,85%
Coegin Pharma is a Swedish biotechnology company with dermacosmetic projects for hair growth and skin pigmentation, as well as drug candidates for the treatment of heart attacks and leukemia. What the projects have in common is that they are based on patented technology platforms and collaborations with researchers and academics internationally. Coegin Pharma has its headquarters in Lund.
Læs mereMarkedsværdi
111,95 mio. SEK
Aktieomsætning
296,11 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
22.5
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '25
21.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Coegin Pharma AB (publ) publishes its year-end report for 2024
Groundbreaking cancer treatment research published in "Nature Communications"
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools